180 related articles for article (PubMed ID: 28328615)
1. Patient-Reported Experience of Diagnosis, Management, and Burden of Neuroendocrine Tumors: Results From a Large Patient Survey in the United States.
Wolin EM; Leyden J; Goldstein G; Kolarova T; Hollander R; Warner RRP
Pancreas; 2017; 46(5):639-647. PubMed ID: 28328615
[TBL] [Abstract][Full Text] [Related]
2. Patient-Reported Burden of a Neuroendocrine Tumor (NET) Diagnosis: Results From the First Global Survey of Patients With NETs.
Singh S; Granberg D; Wolin E; Warner R; Sissons M; Kolarova T; Goldstein G; Pavel M; Öberg K; Leyden J
J Glob Oncol; 2017 Feb; 3(1):43-53. PubMed ID: 28717741
[TBL] [Abstract][Full Text] [Related]
3. Patient-reported experience of the impact and burden of neuroendocrine tumors: Oceania patient results from a large global survey.
Leyden J; Pavlakis N; Chan D; Michael M; Clarke S; Khasraw M; Price T
Asia Pac J Clin Oncol; 2018 Jun; 14(3):256-263. PubMed ID: 29105989
[TBL] [Abstract][Full Text] [Related]
4. Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Leyden S; Kolarova T; Bouvier C; Caplin M; Conroy S; Davies P; Dureja S; Falconi M; Ferolla P; Fisher G; Goldstein G; Hicks RJ; Lawrence B; Majima Y; Metz DC; O'Toole D; Ruszniewski P; Wiedenmann B; Hollander R;
Int J Cancer; 2020 Mar; 146(5):1316-1323. PubMed ID: 31509608
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Symptoms Burden in Neuroendocrine Tumors: A Population-Based Analysis of Prospective Patient-Reported Outcomes.
Hallet J; Davis LE; Mahar AL; Law CHL; Isenberg-Grzeda E; Bubis LD; Singh S; Myrehaug S; Zhao H; Beyfuss K; Moody L; Coburn NG
Oncologist; 2019 Oct; 24(10):1384-1394. PubMed ID: 31270268
[TBL] [Abstract][Full Text] [Related]
6. The German NET-registry: an audit on the diagnosis and therapy of neuroendocrine tumors.
Ploeckinger U; Kloeppel G; Wiedenmann B; Lohmann R;
Neuroendocrinology; 2009; 90(4):349-63. PubMed ID: 19776553
[TBL] [Abstract][Full Text] [Related]
7. Patient reported experience of the burden of neuroendocrine tumors and impact of eSHINE Patient Support Program on patient quality of life.
Wakelin K
Asia Pac J Clin Oncol; 2020 Nov; 16 Suppl 7():3-8. PubMed ID: 33145888
[TBL] [Abstract][Full Text] [Related]
8. Living With Neuroendocrine Tumors: Assessment of Quality of Life Through a Mobile Application.
Adams JR; Ray D; Willmon R; Pulgar S; Dasari A
JCO Clin Cancer Inform; 2019 Jul; 3():1-10. PubMed ID: 31283354
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and Satisfaction of Using NET VITALS Self-assessment Tool Among Patients With Neuroendocrine Tumors.
Li D; Imbesi GJ; Yen L; Kim H; Sun CL; Crook CJ; Ballena R; Zhang YH; Allen R; Sedrak M; Singh G
Pancreas; 2022 Apr; 51(4):319-324. PubMed ID: 35775639
[TBL] [Abstract][Full Text] [Related]
10. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus).
Phan AT; Oberg K; Choi J; Harrison LH; Hassan MM; Strosberg JR; Krenning EP; Kocha W; Woltering EA; Maples WJ;
Pancreas; 2010 Aug; 39(6):784-98. PubMed ID: 20664476
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in patients with neuroendocrine tumors: an investigation of treatment type, disease status, and symptom burden.
Pearman TP; Beaumont JL; Cella D; Neary MP; Yao J
Support Care Cancer; 2016 Sep; 24(9):3695-703. PubMed ID: 27029477
[TBL] [Abstract][Full Text] [Related]
12. Comparison of health-related quality of life in patients with neuroendocrine tumors with quality of life in the general US population.
Beaumont JL; Cella D; Phan AT; Choi S; Liu Z; Yao JC
Pancreas; 2012 Apr; 41(3):461-6. PubMed ID: 22422138
[TBL] [Abstract][Full Text] [Related]
13. The unmet supportive care needs, quality of life, and care experiences of patients with functioning and non-functioning Neuroendocrine tumours (NETs) at early diagnosis.
Guccione L; Gough K; Drosdowsky A; Price T; Pavlakis N; Wyld D; Ransom D; Michael M; Schofield P
Patient Educ Couns; 2022 Jan; 105(1):212-220. PubMed ID: 34030927
[TBL] [Abstract][Full Text] [Related]
14. Future perspectives on neuroendocrine tumors.
Castellano D; Salazar R; Raymond E
Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():35-40. PubMed ID: 21327890
[TBL] [Abstract][Full Text] [Related]
15. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
[TBL] [Abstract][Full Text] [Related]
16. Patient experiences of having a neuroendocrine tumour: a qualitative study.
Feinberg Y; Law C; Singh S; Wright FC
Eur J Oncol Nurs; 2013 Oct; 17(5):541-5. PubMed ID: 23522828
[TBL] [Abstract][Full Text] [Related]
17. Clinical aspects, diagnostic challenges and management of patients with neuroendocrine tumors (NETs).
Spizzo G; Bernardini K; Pieramico O; Buratti T; Platzgummer S; Farsad M; Schmitt AM; Perren A; Vogelsang H; Promegger R; Bale R; Gabriel M; Nevinny M; Gastl G; Mitterer M
Onkologie; 2011; 34(3):139-46. PubMed ID: 21358221
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine Tumors of the Lung: Current Challenges and Advances in the Diagnosis and Management of Well-Differentiated Disease.
Hendifar AE; Marchevsky AM; Tuli R
J Thorac Oncol; 2017 Mar; 12(3):425-436. PubMed ID: 27890494
[TBL] [Abstract][Full Text] [Related]
19. A Step-by-Step Clinical Approach for the Management of Neuroendocrine Tumours.
Yordanova A; Ahmadzadehfar H; Gonzalez-Carmona M; Strassburg C; Mayer K; Feldmann G; Schmidt-Wolf I; Lingohr P; Fischer S; Kristiansen G; Essler M
Horm Metab Res; 2017 Feb; 49(2):77-85. PubMed ID: 28099977
[TBL] [Abstract][Full Text] [Related]
20. NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.
Shah MH; Goldner WS; Halfdanarson TR; Bergsland E; Berlin JD; Halperin D; Chan J; Kulke MH; Benson AB; Blaszkowsky LS; Eads J; Engstrom PF; Fanta P; Giordano T; He J; Heslin MJ; Kalemkerian GP; Kandeel F; Khan SA; Kidwai WZ; Kunz PL; Kuvshinoff BW; Lieu C; Pillarisetty VG; Saltz L; Sosa JA; Strosberg JR; Sussman CA; Trikalinos NA; Uboha NA; Whisenant J; Wong T; Yao JC; Burns JL; Ogba N; Zuccarino-Catania G
J Natl Compr Canc Netw; 2018 Jun; 16(6):693-702. PubMed ID: 29891520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
